CollPlant Biotechnologies (CLGN) Change in Receivables (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Change in Receivables of $10000.0 for Q4 2025, up 190.91% on a QoQ basis from -$11000.0 in Q3 2025, and up 106.9% year-over-year from $4833.3 in Q4 2024.
CollPlant Biotechnologies (CLGN) Change in Receivables (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Change in Receivables history runs 8 years deep, the most recent figure standing at $10000.0 for Q4 2025.
- Quarterly Change in Receivables rose 106.9% year-over-year to $10000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$146000.0 (up 2.67% YoY) and the FY2025 annual result came in at $149000.0, up 199.33% from the prior year.
- Change in Receivables was $10000.0 for Q4 2025 at CollPlant Biotechnologies, up from -$11000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $10.2 million in Q3 2023 and bottomed at -$9.8 million in Q2 2023.
- A 5-year average of $96176.5 and a median of $4000.0 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2021 — Change in Receivables jumped 305.64% — and 2023, when it sank 109200.0%.
- CollPlant Biotechnologies' Change in Receivables stood at $560000.0 in 2021, then tumbled by 53.39% to $261000.0 in 2022, then tumbled by 98.47% to $4000.0 in 2023, then tumbled by 3725.0% to -$145000.0 in 2024, then surged by 106.9% to $10000.0 in 2025.
- Business Quant data shows CLGN's Change in Receivables at $10000.0 in Q4 2025, -$11000.0 in Q3 2025, and -$145000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Sep 30, 2024 | 245,000.00 |
| Sep 30, 2024 | 245,000.00 |
| Jun 30, 2024 | -160,000.00 |
| Jun 30, 2024 | -160,000.00 |
| Mar 31, 2024 | -90,000.00 |
| Mar 31, 2024 | -90,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 10.16 Mn |
| Sep 30, 2023 | 10.16 Mn |
| Jun 30, 2023 | -9.84 Mn |
| Jun 30, 2023 | -9.84 Mn |
| Mar 31, 2023 | -314,000.00 |
| Mar 31, 2023 | -314,000.00 |